இசைக்கருவி வகை மாத்திரை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from இசைக்கருவி வகை மாத்திரை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In இசைக்கருவி வகை மாத்திரை Today - Breaking & Trending Today

Intec Announces Expected Closing Date of Decoy Merger

Intec Announces Expected Closing Date of Decoy Merger
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Israel General , Wintec Pharma , Intec Parent Inc , Exchange Commission On , Indaptus Therapeutics Inc , Company Accordion Pill , Prnewswire Intec Parent Inc , Exchange Commission , Intec Pharma Ltd , Company The Domestication Merger , Nasdaq Stock Market , Decoy Biosystems Inc , Securities Exchange , Decoy Biosystems , Nasdaq Capital Market , Decoy Merger , Securities Exchange Act , Domestication Merger , Investor Relations , Accordion Pill , Private Securities Litigation Reform , Intec Parent , Parent Investor Contact , ஈந்தெக் பார்மா , பரிமாற்றம் தரகு ஆன் , நிறுவனம் இசைக்கருவி வகை மாத்திரை ,

Stockholder Alleges Intec Pharma's Registration Statement for Proposed Merger Misled Investors

Health
your username
6 days ago
A stockholder is suing Intec Pharma Ltd., Intec’s board of directors, and related entities over alleged violations of the Securities Exchange Act, per a Friday complaint filed in the District of Delaware regarding a proposed merger.
Plaintiff Craig Davidson is an owner of common stock of Intec, a biopharmaceutical company developing drug products based on its Accordion Pill platform that seeks to “improve the efficacy and safety” of drug products. On March 15, Intec’s board of directors executed a merger agreement with Intec Parent, Inc., Dillion Merger Subsidiary Inc., Domestication Merger Sub Ltd., and Decoy Biosystems Inc. The companies said in a news release that they are aiming for the merger to be executed in the third quarter of 2021, the complaint detailed. A registration statement with the Securities and Exchange Commission (SEC) followed on April 20. ....

United States , Craig Davidson , Exchange Commission , Intec Parent Inc , Dillion Merger Subsidiary Inc , Intec Pharma Ltd , Domestication Merger Sub Ltd , Securities Exchange , Decoy Biosystems Inc , Securities Exchange Act , Accordion Pill , Intec Parent , Decoy Biosystems , Registration Statement , ஒன்றுபட்டது மாநிலங்களில் , கிரேக் டேவிட்சன் , பரிமாற்றம் தரகு , ஈந்தெக் பார்மா லிமிடெட் , பத்திரங்கள் பரிமாற்றம் , சிதைவு உயிர் அமைப்புகள் இன்க் , பத்திரங்கள் பரிமாற்றம் நாடகம் , இசைக்கருவி வகை மாத்திரை , சிதைவு உயிர் அமைப்புகள் , பதிவு அறிக்கை ,

Intec Pharma Announces Filing of 2020 Annual Report on Form 10-K

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Intec Pharma Announces Filing of 2020 Annual Report on Form 10-K
Intec Pharma LtdMarch 17, 2021 GMT
JERUSALEM , March 16, 2021 (GLOBE NEWSWIRE) Intec Pharma Ltd. (NASDAQ: NTEC) (“Intec” or “the Company”) today announces that it has filed its annual report on Form 10-K for the year ended December 31, 2020 with the U.S. Securities and Exchange Commission. A copy of the annual report is available on Intec’s website, www.intecpharma.com, by selecting “Investors” and then “Financials” and “SEC Filings”.
You may request a copy of the Company’s Form 10-K, at no cost to you, by writing to the Chief Financial Officer of the Company at 12 Hartom Street, Har Hotzvim, Jerusalem 9777512, Israel or by calling the Company at +972 (2) 586 4657. ....

Israel General , Wintec Pharma , Har Hotzvim , Exchange Commission , Company Form , Intec Pharma Ltd , Company Accordion Pill , Chief Financial Officer , Accordion Pill , Investor Relations , Proposed Merger , Decoy Biosystems , Registration Statement , Decoy Biosystem , Annual Report , Private Securities Litigation Reform , Pharma Investor Contact , Corporate News , Pharmaceutical Manufacturing , Government Regulations , Ownership Changes , Middle East , Sec Filings , Product Approvals , New Products And Services , Government And Politics ,

Intec Pharma and Decoy Biosystems Announce Merger Agreement

Intec Pharma and Decoy Biosystems Announce Merger Agreement
USA - English
Investigational New Drug Application Filing Expected in 2H 2021
News provided by
Share this article
Share this article
JERUSALEM, March 15, 2021 /PRNewswire/ Intec Pharma Ltd. (NASDAQ: NTEC) ( Intec or the Company ) announced today that it has entered into a definitive agreement for a business combination with Decoy Biosystems, Inc., a privately-held, preclinical-stage biotechnology company developing novel, multi-targeted products that safely prime both innate and adaptive anti-tumor and anti-viral immune responses.
The combined company will advance its immunotherapy platform to battle a variety of tumor types and chronic viral infections. Decoy previously held a pre-IND meeting with the FDA, currently plans to file an IND in the second half of 2021 and to initiate a Phase I clinical trial in 2022 targeting solid tumors and lymphomas. ....

Israel General , San Diego , United States , Wintec Pharma , Roger Pomerantz , Har Hotzvim , Michaelj Newman , Jeffreya Meckler , Prnewswire Intec Pharma Ltd , Intec Pharma Ltd , Company Current Report On Form , Decoy Biosystems Inc , Company Accordion Pill , Decoy Biosystems , Vice Chairman , Chief Executive Officer , Accordion Pill , Jeffrey Meckler , Michael Newman , Chief Scientific Officer , Johnson Innovation , Investor Relations , Proposed Merger , Registration Statement , Decoy Biosystem , Annual Report ,

Best Penny Stocks To Buy Now? 5 For Your Watch List

Best Penny Stocks To Buy Now? 5 For Your Watch List
dailyherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyherald.com Daily Mail and Mail on Sunday newspapers.

United States , Sanjays Shukla , Wintec Pharma , Alex Ovadia , Robert Cohen , James Sapirstein , Jeffreya Meckler , Ppd Inc , Zomedica Corp , Federal Reserve , Atyr Pharma Inc , American Association For Cancer Research , Cap Ltd , Decoy Biosystems Inc , Azurrx Biopharma Inc , Maxim Group Emerging Growth Conference , For Your Penny Stocks , Cap Index , Penny Stocks To Buy , Stocks To Buy , Device Exemption , Chief Executive Officer , Breakthrough Device Designation , Azurrx Biopharma , Preferred Shares , Accordion Pill ,